Medicalgorithmics Signs Its Third U.S. Agreement This Year
Polish medtech company Medicalgorithmics has signed another agreement with a leading U.S.-based diagnostics firm – ACS Diagnostics Inc. Under the agreement, the company’s innovative DeepRhythm Platform (DRP) and DeepRhythmAI (DRAI) artificial intelligence algorithms will be integrated with the partner’s flagship device – the multifunctional CORE 3 ECG patch, which holds FDA certification. This marks the tenth agreement signed by Medicalgorithmics in 2025, and the third one with a U.S. partner, confirming the rapidly growing interest in the company’s software and AI algorithms following the breakthrough publication of research results using its AI technology in Nature Medicine.